Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
GH
Guardant Health, Inc.
NASDAQGS
Diagnostics & Research
United States
$161.41
▲
+0.37 (+0.23%)
CLOSED
—
OPEN
$160.00
HIGH
$164.84
LOW
$154.00
PREV CLOSE
$161.04
VOLUME
2.40M
0.95x avg
BID / ASK
146.23 / 191.82
spr 45.59
MARKET CAP
$21.66B
DAY RANGE
$154.00
$164.84
P/E (TTM)
—
Fwd -364.9
EPS (TTM)
-3.50
DIV YIELD
—
52W HIGH
$176.58
-8.6%
52W LOW
$53.40
+202.3%
BETA
1.58
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$162.5
+1.09
(+0.68%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
GH
$161.41
▲
+0.23%
Chart
Valuation
Financials
Peers
News
GH · K 線技術分析（即時、可互動）
basic
pro
快速分析（2–5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，一般約 2 分鐘，上游壅塞時最長約 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-ON
252 BARS · +168.4% YOY
1-year price chart. Started at 60.13, currently 161.41, up 168.4 percent. Range 54.79 to 170.92 over 252 data points.
2025-09-05
$60.13 → $161.41 (+168.4%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
—
WACC Used
+7.5%
Terminal g
+3.0%
同業:
AGX PE33
ADEA PE24
ADTN
AEIS PE52
AEHR
AFRM PE13
AIRJW
AKTS
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
多年財務（SEC XBRL）
RISK-ON
YOY REV +32.9% · 3 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$982.0M
-$416.3M
-$184.8M
-$233.1M
$2.01B
2024-12
$739.0M
-$436.4M
-$239.9M
-$274.9M
$1.49B
2023-12
$563.9M
-$479.4M
-$325.0M
-$345.5M
$1.79B
PEERS
同業與產業對照
CALM
10 PEERS · FINNHUB
AGX
ADEA
ADTN
AEIS
AEHR
AFRM
AIRJW
AKTS
ALH
APLD
NEWS
近期新聞（過去 14 天）
CALM
10 HEADLINES · LAST 14 DAYS
Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection
Insider Monkey · 2026-09-05
Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Breast Cancer
Business Wire · 2026-09-04
Guardant Health Expands Shield Blood Test Coverage Through Carelon
MT Newswires · 2026-09-01
Guardant Health’s Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening
Business Wire · 2026-09-01
Guardant Health (GH) Stock Could Trade At A 21% Discount Despite Patent Appeal
Simply Wall St. · 2026-08-27
Did a US$245 Million Patent Ruling Just Shift Guardant Health's (GH) Investment Narrative?
Simply Wall St. · 2026-08-27
Has Guardant Health (GH) Run Too Far After Its US$245 Million Patent Ruling?
Simply Wall St. · 2026-08-26
Guardant Health ordered to pay $245M in patent dispute
MedTech Dive · 2026-08-26